Savers Value Village insider sells 12,402 shares after option exercise
Rhea-AI Filing Summary
Savers Value Village director William T. Allen reported option exercises and a sale of common stock on 08/15/2025. He exercised 12,402 options with a $1.41 exercise price and immediately sold 12,402 shares at $11.15 each under a 10b5-1 plan adopted May 15, 2025, leaving him with 16,655 shares directly owned. After the exercise, he beneficially owns 43,820 shares in total, including 12,402 shares underlying vested options that expire 06/28/2029. The filing was signed by an attorney-in-fact on 08/19/2025.
Positive
- Transactions conducted under a 10b5-1 plan, indicating pre-planned trading rules were followed
- Options exercised had a low exercise price ($1.41), producing intrinsic value when sold at $11.15
- Reporting person retains meaningful beneficial ownership (43,820 shares including options)
Negative
- Insider sold 12,402 shares, which reduces the director's direct share count from 29,057 to 16,655
- Substantial portion of option awards are performance-based and remain subject to future vesting conditions
Insights
TL;DR: Insider exercised vested options and sold exercised shares under a pre-established 10b5-1 plan; routine director liquidity event.
The report shows a director-level insider exercised fully vested options and executed an immediate sale for liquidity via a 10b5-1 plan adopted May 15, 2025. The options exercised had a low $1.41 strike relative to the sale price of $11.15, realizing intrinsic value. Remaining beneficial ownership of 43,820 shares includes both exercised shares and unexercised options that expire in 2029. This is a standard, non-accelerated transaction consistent with pre-planned trading and option vesting schedules disclosed in the filing.
TL;DR: The insider sale is structured and disclosed; not necessarily a signal of company performance.
The filing documents that 12,402 options vested and were exercised; the sale of those shares was executed under a Rule 10b5-1 plan. The sale price of $11.15 compared with the $1.41 exercise price indicates a material gain to the reporting person but the motion appears procedural rather than reactive. The director retains significant holdings totaling 16,655 directly owned shares post-sale and 43,820 shares beneficially owned when including option interests, which maintains alignment with shareholders.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option (Right to Purchase) | 12,402 | $1.41 | $17K |
| Exercise | Common Stock | 12,402 | $1.41 | $17K |
| Sale | Common Stock | 12,402 | $11.15 | $138K |
Footnotes (1)
- The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on May 15, 2025. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The June 28, 2019 stock option grant vested in substantially equal annual installments over five years starting May 20, 2020, and was fully vested on May 20, 2024. Approximately 15% represents time-based options with a vesting schedule in substantially equal annual installments over five years starting May 2, 2020, and approximately 85% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.
